Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENVB | AMGN | VRTX | REGN | GILD |
| Company | Enveric Biosciences Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.5200 | 333.23 | 497.00 | 1,075.35 | 72.89 |
| High | 0.5300 | 336.35 | 498.77 | 1,078.71 | 73.32 |
| Low | 0.4500 | 332.47 | 491.52 | 1,064.95 | 72.02 |
| Last | 0.4660 | 335.37 | 494.47 | 1,071.59 | 72.29 |
| Change | -0.0040 | +4.08 | +2.90 | +7.99 | -0.27 |
| % Change | -0.85% | +1.23% | +0.59% | +0.75% | -0.37% |
| Volume | 496,725 | 748,024 | 492,649 | 116,125 | 1,761,948 |
| 20-Day Average Volume | 344,719 | 2,035,966 | 1,114,250 | 416,506 | 6,318,075 |
| Previous Close | 0.4700 | 331.29 | 491.57 | 1,063.60 | 72.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5414 | 320.97 | 481.88 | 1,064.49 | 69.77 |
| 20-Day Raw Stochastic | 21.82% | 87.19% | 89.88% | 64.30% | 69.47% |
| 20-Day Relative Strength | 32.70% | 67.90% | 67.46% | 58.43% | 61.81% |
| Weighted Alpha | -87.33 | +41.39 | +44.14 | +42.83 | -5.19 |
| Today's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 64% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.98% since 07/15/24 | +1.40% since 07/15/24 | +0.94% since 07/15/24 | -0.89% since 07/15/24 | +1.96% since 07/15/24 |
| Low | 0.4250 on 07/19/24 | 328.00 on 07/16/24 | 478.78 on 07/17/24 | 1,060.74 on 07/19/24 | 70.33 on 07/16/24 |
| High | 0.5499 on 07/17/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,100.08 on 07/16/24 | 74.92 on 07/18/24 |
| 1-Month | |||||
| %Chg | -23.31% since 06/21/24 | +8.64% since 06/21/24 | +5.71% since 06/21/24 | +1.83% since 06/21/24 | +2.16% since 06/21/24 |
| Low | 0.4100 on 07/09/24 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 0.6845 on 06/26/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 3-Month | |||||
| %Chg | -45.42% since 04/22/24 | +23.12% since 04/22/24 | +23.89% since 04/22/24 | +19.14% since 04/22/24 | +7.84% since 04/22/24 |
| Low | 0.4100 on 07/09/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 1.0300 on 05/08/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 6-Month | |||||
| %Chg | -53.48% since 01/22/24 | +7.93% since 01/22/24 | +12.58% since 01/22/24 | +13.75% since 01/22/24 | -7.94% since 01/22/24 |
| Low | 0.4100 on 07/09/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 2.9200 on 02/29/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 81.06 on 01/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,738 | 177,715,552 | 126,851,120 | 117,193,824 | 90,399,088 |
| Shares Outstanding, K | 7,954 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -17,290,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -2,460,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 0.74 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.61 on 05/14/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/12/24 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.77 | 32.41 | 28.76 | 18.24 |